EUVIMEDEUVIMED entdecken
Crossref

A Review: Artificial Intelligence in Clinical Trails: Applications, Challenges and Future Perspectives

Anisha Dhuldev Sarje, Ashwini Aba Sargar, Snehal Govind Khatkale, B. S. Karande, A. B. Waghmode

International Journal for Research in Applied Science and Engineering Technology · 31.10.2026 · 14 (10) · 2010-2017

DOI: 10.22214/ijraset.2026.85544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal for Research in Applied Science and Engineering Technology, online erschienen am 31.10.2026. Verfasst von Anisha Dhuldev Sarje und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials are an essential component of drug development and are conducted to establish the safety, efficacy and quality of new medicines and therapeutic interventions. However, conventional clinical trials are often associated with high cost, prolonged duration, complex protocols, difficulties in patient recruitment, large volumes of data and challenges in monitoring. Artificial Intelligence (AI), including machine learning, deep learning, natural language processing and large language models, has emerged as a promising technology for improving different stages of clinical trials. AI can assist in protocol design, patient identification and recruitment, eligibility screening, trial-site selection, data management, patient retention, safety monitoring and prediction of clinical outcomes. Recent research indicates that AI-based approaches may improve the efficiency of recruitment and clinical-trial risk assessment, although their performance depends strongly on data quality, validation and appropriate implementation. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly developing frameworks for responsible use of AI in medicines development. Despite its potential, AI implementation is associated with challenges including algorithmic bias, data privacy, lack of transparency, interoperability, regulatory uncertainty and the need for human oversight. This review discusses the major applications, advantages, limitations, regulatory considerations and future perspectives of AI in clinical trials.

Zitieren

APA

Sarje, A. D., Sargar, A. A., Khatkale, S. G., Karande, B. S., & Waghmode, A. B. (2026). A Review: Artificial Intelligence in Clinical Trails: Applications, Challenges and Future Perspectives. International Journal for Research in Applied Science and Engineering Technology, 14(10), 2010-2017. https://doi.org/10.22214/ijraset.2026.85544

Vancouver

Sarje AD, Sargar AA, Khatkale SG, Karande BS, Waghmode AB. A Review: Artificial Intelligence in Clinical Trails: Applications, Challenges and Future Perspectives. International Journal for Research in Applied Science and Engineering Technology. 2026;14(10):2010-2017. doi:10.22214/ijraset.2026.85544

BibTeX
@article{Sarje2026,
  author = {Sarje, Anisha Dhuldev and Sargar, Ashwini Aba and Khatkale, Snehal Govind and Karande, B. S. and Waghmode, A. B.},
  title = {A Review: Artificial Intelligence in Clinical Trails: Applications, Challenges and Future Perspectives},
  journal = {International Journal for Research in Applied Science and Engineering Technology},
  year = {2026},
  volume = {14},
  number = {10},
  pages = {2010--2017},
  doi = {10.22214/ijraset.2026.85544}
}
Kostenlos starten →